World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 3 August 2015
Main ID:  NCT02212223
Date of registration: 06/08/2014
Prospective Registration: Yes
Primary sponsor: Helsinki University
Public title: Marwo-D Research -Need for Vitamin D in Different Population Groups ODIN
Scientific title: Food-based Solutions for Optimal Vitamin D Nutrition and Health Through the Life Cycle (ODIN)
Date of first enrolment: September 2014
Target sample size: 147
Recruitment status: Completed
URL:  https://clinicaltrials.gov/show/NCT02212223
Study type:  Interventional
Study design:  Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Prevention  
Phase:  N/A
Countries of recruitment
Finland
Contacts
Name:     Christel Lamberg-Allardt, Professor
Address: 
Telephone:
Email:
Affiliation:  Helsinki University
Key inclusion & exclusion criteria

Inclusion Criteria:

- woman between 21-66 years of age

- belongs to original Finnish population or to Somali immigrant population

- healthy (= no disease requiring medication)

- lives in the metropolitan area

Exclusion Criteria:

- pregnant or breastfeeding

- has traveled to a sunny destination or destination near the equator during the
previous month

- plans to travel to a sunny destination or destination near the equator in the next 6
months

- has used a tanning bed during the previous month

- plans to use a tanning bed in the next 6 months

- the subject's blood 25-hydroxy-vitamin D level (25 (OH) D), exceeds 100 nmol / L or
is less than 30 nmol / L at baseline in the screening phase.



Age minimum: 21 Years
Age maximum: 66 Years
Gender: Female
Health Condition(s) or Problem(s) studied
Serum 25-hydroxyvitamin D Concentrations (25OHD)
Intervention(s)
Dietary Supplement: Vitamin D3
Primary Outcome(s)
Serum 25-hydroxyvitamin D (25(OH)D) concentrations [Time Frame: Change from baseline in serum 25(OH)D concentration at 3 and 6 months]
Secondary Outcome(s)
Serum calcium concentration [Time Frame: Change from baseline in serum calcium concentration at 3 and 6 months]
Serum parathyroid hormone (PTH) concentration [Time Frame: Change from baseline in serum PTH concentration at 3 and 6 months]
Secondary ID(s)
Helsinki U
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
National Institute for Health and Welfare, Finland
Technical University of Denmark
University College Cork
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history